| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |